HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marked efficacy of vemurafenib in suprasellar Erdheim-Chester disease.

AuthorsFleur Cohen-Aubart, Jean-François Emile, Philippe Maksud, Damien Galanaud, Ahmed Idbaih, Dorian Chauvet, Yaël Amar, Neila Benameur, Zahir Amoura, Julien Haroche
JournalNeurology (Neurology) Vol. 83 Issue 14 Pg. 1294-6 (Sep 30 2014) ISSN: 1526-632X [Electronic] United States
PMID25171932 (Publication Type: Case Reports, Journal Article, Observational Study)
Chemical References
  • Indoles
  • Protein Kinase Inhibitors
  • Sulfonamides
  • Vemurafenib
Topics
  • Erdheim-Chester Disease (complications, drug therapy, pathology)
  • Head (pathology)
  • Humans
  • Indoles (therapeutic use)
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Positron-Emission Tomography
  • Protein Kinase Inhibitors (therapeutic use)
  • Sulfonamides (therapeutic use)
  • Treatment Outcome
  • Vemurafenib
  • Vision Disorders (etiology, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: